News tagged with stimulant drugs

Added benefit of lisdexamfetamine is not proven

Lisdexamfetamine dimesylate (trade name: Elvanse) has been approved in Germany since March 2013 as part of a comprehensive treatment programme for attention deficit/hyperactivity disorder (ADHD) in children aged 6 years and ...

Sep 03, 2013
popularity not rated yet | comments 0

FDA warns consumers of dangers of the stimulant DMAA

(HealthDay)—The U.S. Food and Drug Administration is attempting to halt distribution of dietary supplements that contain the stimulant dimethylamylamine (DMAA), following reports of illness and death associated ...

Apr 15, 2013
popularity 5 / 5 (2) | comments 0